Announcements Trials
Browse Landscape

Phase

Phase NA 6

Status

Completed 5Withdrawn 1Terminated 1

Sponsor Class

OTHER 14INDUSTRY 7NETWORK 1FED 1

Study Type

Interventional 6Observational 1

Sponsor

Conditions

Leiomyoma 7Myoma 3Menorrhagia 3Polyps 1Pelvic Pain 1Hemorrhage 1Agnosia 1

Interventions

pembrolizumab 1033Carboplatin 971Paclitaxel 942Gemcitabine 799Cisplatin 757Docetaxel 698Bevacizumab 637Nivolumab 520Pemetrexed 507Capecitabine 475Cyclophosphamide 473Fluorouracil 425Dexamethasone 410Rituximab 391Oxaliplatin 352Injections 347Trastuzumab 313atezolizumab 312Cetuximab 291Leucovorin 290Irinotecan 271130-nm albumin-bound paclitaxel 257Prednisone 251Ipilimumab 244Doxorubicin 241Lenalidomide 231Fulvestrant 226fludarabine 219durvalumab 211Erlotinib Hydrochloride 196

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
INDUSTRY × Uterine Myomectomy × Clear all
NCT02163525 2025-09-30

Post Market TRUST - U.S.A. Study

Acessa Health, Inc.

Phase NA Completed
114 enrolled

Leiomyoma, Menorrhagia, Myoma

NCT01563783 2023-02-01

TRUST

Acessa Health, Inc.

Phase NA Completed
84 enrolled

Leiomyoma, Menorrhagia, Myoma

NCT01750008 2018-11-20

LUSTOR

Acessa Health, Inc.

Phase NA Completed
51 enrolled

Leiomyoma, Menorrhagia, Myoma

NCT00730886 2018-08-15

ExAblate Treatment of Uterine Fibroids for Fertility Enhancement

InSightec

Phase NA Terminated
2 enrolled 6 charts

Leiomyoma

NCT01328067 2018-06-15

Study to Evaluate the Safety and Effectiveness of MRgFUS Compared With Myomectomy for the Treatment of Uterine Fibroids

InSightec

Phase NA Withdrawn

Hemorrhage, Leiomyoma, Pelvic Pain

NCT01152112 2017-09-13

HOME

Hologic, Inc.

Phase NA Completed
74 enrolled 5 charts

Agnosia, Leiomyoma, Polyps

NCT02819609 2016-06-30

Comparing Patient-Centered Outcomes After Treatment for Uterine Fibroids

Quintiles, Inc.

Completed
12,234 enrolled

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡